Related Experiment Video
Updated: Apr 23, 2026
03:17
Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
1.1K
Early therapy for type 2 diabetes in China
1China-Japan Friendship Hospital, Beijing, China.
The Lancet. Diabetes & Endocrinology
|September 15, 2014
Summary
Optimal diabetes treatments for Chinese patients are crucial due to unique characteristics like β-cell deterioration. Early therapy should focus on controlling postprandial hyperglycemia and preserving beta-cell function.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Diabetes mellitus affects approximately 100 million individuals in China, representing a significant public health challenge.
- Chinese patients with type 2 diabetes (T2DM) exhibit distinct physiological traits, including lower body weight and pronounced beta-cell deterioration, leading to impaired insulin secretion.
- This results in more severe postprandial hyperglycemia in early-stage T2DM Chinese patients compared to other ethnic groups.
Purpose of the Study:
- To identify optimal therapeutic strategies for Chinese patients with type 2 diabetes.
- To address the specific challenges posed by beta-cell deterioration and postprandial hyperglycemia in this population.
- To guide the development of evidence-based treatment guidelines tailored for Chinese T2DM patients.
Main Methods:
- Review of current treatment recommendations and clinical characteristics of Chinese patients with type 2 diabetes.
- Analysis of therapeutic approaches targeting postprandial hyperglycemia and beta-cell preservation.
- Identification of evidence gaps in antidiabetic drug efficacy and safety for the Chinese population.
Main Results:
- Key therapeutic strategies for Chinese T2DM patients include managing postprandial hyperglycemia and preserving beta-cell function.
- Recommended first-line drugs for drug-naive patients include metformin, insulin secretagogues, and alpha-glucosidase inhibitors.
- Short-term intensive insulin therapy may restore beta-cell function in severe cases, and incretin-based drugs are options for treatment failure.
Conclusions:
- Tailored treatment strategies are essential for Chinese patients with type 2 diabetes, focusing on their unique pathophysiology.
- Further research is required to strengthen evidence-based guidelines for managing diabetes in China.
- Addressing specific patient characteristics can improve therapeutic outcomes and disease management.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
01:26Type II Diabetes I: Introduction
8
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
9
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
9
01:24Type II Diabetes II: Pathophysiology
8
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
8
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
01:36Carbohydrate Metabolism
10.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.4K